Your Article Summary
See Latest ArticlesPrognostic significance of a pretreatment hematologic profile in patients with head and neck cancer
Journal of Cancer Research & Clinical Oncology, 06/30/09
Chen MH et al. - In a study to test whether the pretreatment hematologic profile can predict prognosis of pts with head and neck cancer (HNC), it was shown that a pretreatment hematologic profile can be considered as a useful prognostic marker in pts with HNC.
Methods- Medical records from 278 pts with HNC were reviewed, and 270 cases were evaluable.
- Clinical data including age, gender, stage, pretreatment hematologic profile (including white blood cell, platelet, and differential counts, and hemoglobin level) were recorded.
- Statistical analyses were performed to determine the prognostic effect of these hematologic indicators, as well as clinical variables.
- Association between hematologic indicators and clinical factors was also analyzed.
- Pretreatment monocytes >1000 cells/μl, hemoglobin <11.0 g/dl, and platelet count >400 x 103 cells/μl were identified as independent prognostic factors in addition to nodal status and metastasis.
- A significant correlation between T-stage/monocyte or platelet count and metastasis/platelet count were shown.
- Monocytosis, anemia, and thrombocytosis were demonstrated to have a cumulative effect on prognosis of HNC pts (normal vs abnormality in 1 lineage; abnormality in 1 vs >1 lineage).
Related Articles
Cessation of alcohol drinking, tobacco smoking and the reversal of head and neck cancer risk
International Journal of Epidemiology, 10/08/09
Relevance Score: 84%
Planned neck dissection following primary chemoradiation for advanced-stage head and neck cancer
Otolaryngology Head and Neck Surgery, 10/13/09
Relevance Score: 83%
Extracts from The Cochrane Library: Erythropoietin as an adjuvant treatment with (chemo) radiation therapy for head and neck cancer
Otolaryngology Head and Neck Surgery, 10/12/09
Relevance Score: 83%
Clinical Features and Short-Term Outcome of Critically Ill Patients With Head and Neck Cancer in the Medical Intensive Care Unit
American Journal of Clinical Oncology, 10/07/09
Relevance Score: 83%
Sheddase Activity of Tumor Necrosis Factor-alpha Converting Enzyme Is Increased and Prognostically Valuable in Head and Neck Cancer
Cancer Epidemiology, Biomarkers & Prevention, 10/27/09
Relevance Score: 82%
Today in Head and Neck...keeping you current
Receive free subspecialty "5-minute updates" via email
Preoperative predictors of sternotomy need in mediastinal goiter management
Head & Neck, 12/04/09
Head and neck cancer in young people: a series of 52 SCCs of the oral tongue in patients aged 35 years or less
Acta Oto-Laryngologica , 12/04/09
Sequential evaluation of swallowing function in patients with unilateral neck dissection
Head & Neck, 12/03/09